Association of quarterly average achieved hematocrit with mortality in dialysis patients: a time-dependent comorbidity-adjusted model.

@article{Messana2009AssociationOQ,
  title={Association of quarterly average achieved hematocrit with mortality in dialysis patients: a time-dependent comorbidity-adjusted model.},
  author={Joseph M Messana and C C Chuang and Marc N. Turenne and John R. C. Wheeler and Jason S Turner and Kathryn K Sleeman and Philip M. Tedeschi and Richard A. Hirth},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  year={2009},
  volume={53 3},
  pages={503-12}
}
BACKGROUND Recent publications suggest that increased mortality is associated with high hematocrit targets in erythropoietin-stimulating agent-treated patients with chronic kidney disease. We aim to further inform the debate about optimal hematocrit targets, advancing the hypothesis that the current hematocrit target may not optimize the survival of patients with end-stage renal disease. STUDY DESIGN Cross-sectional observational study. SETTING & PARTICIPANTS Medicare dialysis patients from… CONTINUE READING